Rate Of Malignant Transformation In High Risk Et During 5 Years Of Follow-Up Of Cytoreductive Therapy

Birgegård, Gunnar (author)

Uppsala universitet,Hematologi

Folkvaljon, Y. (author)

Reg Canc Ctr, Uppsala, Sweden.

Garmo, H. (author)

Reg Canc Ctr, Uppsala, Sweden.

show more...

Besses, C. (author)

Hosp Mar IMIM, Dept Haematol, Barcelona, Spain.

Griesshammer, M. (author)

Johannes Wesling Med Ctr, Hematol & Oncol, Minden, Germany.

Gugliotta, L. (author)

St Orsola Malpighi Hosp, Dept Haematol L&A Seragnoli, Bologna, Italy.

Harrison, C. (author)

Guys & St Thomas NHS Fdn Trust, Dept Haematol, London, England.

Hamdani, M. (author)

Shire Pharmaceut, Global Biometr, Lexington, MA USA.

Wu, J. (author)

Shire Pharmaceut, Global Biometr, Lexington, MA USA.

Achenbach, H. (author)

Shire GmbH, Res & Dev, Zug, Switzerland.

Kiladjian, J. J. (author)

Hop St Louis, APHP, Ctr Invest Clin, Paris, France.

show less...

 (creator_code:org_t)

2016

2016

English.

In: Haematologica. - 0390-6078 .- 1592-8721. ; 101, s. 96-96

Related links:

https://urn.kb.se/re...

• Journal article (other academic/artistic)